Orphan Therapeutics LLC Bookmark and Share

ArticleDateSource
Infinata’s BioPharm Insight Spotlights Orphan Drugs with Exclusive...--PRWeb - Biotechnology
Orphan Drugs Market in Europe 2013: Worldwide Industry Latest Market...--PRWeb - Pharmaceuticals
Orphan Drug Development Continue to See Rapid Growth in Europe,...--PRWeb - Biotechnology
Orphan Drugs Market Partnering Deals and Agreements by Healthcare...--PRWeb - Pharmaceuticals
Orphan Drugs Market - New Industry Research Report is Now Available...--PRWeb - Pharmaceuticals
Strategies for Rare Disease Studies and Orphan Drug Development in the...--PRWeb - Biotechnology
Growth Expected in Orphan Drug Markets: Finds New Kalorama Report--PRWeb - Pharmaceuticals
CBPartners Runs ISPOR Workshop Evaluating Orphan and Ultra-Orphan HTA...--PRWeb - Pharmaceuticals
IRS Draft Rule Defines Orphan Drugs in Context of ACA Tax--Pharmaceutical - Moreover
XOMA Antibody Receives Orphan Drug Designation from the FDA and EMA--Outsourcing - BioPharm
Orphan drug workshops--Nature Biotechnology
Inhibikase Therapeutics drug receives FDA orphan statusMay 21, 2014Health News - BizJournals.com
Edison Pharmaceuticals, Inc.'s EPI-743 Granted Orphan Designation For Leigh Syndrome In Japan May 21, 2014BioSpace - Breaking News
AbbVie Receives Orphan Drug Designation For HUMIRA® (Adalimumab) From The FDA For The Investigational Treatment Of Certain Forms Of Non-Infectious Uveitis May 21, 2014BioSpace - Breaking News
Inhibikase Therapeutics Receives Orphan Drug Designation for treatment of Progressive Multifocal Leukoencephalopathy (PML)May 21, 2014Pharma News - PharmiWeb
Inhibikase Therapeutics Receives Orphan Drug Designation for treatment of Progressive Multifocal Leukoencephalopathy (PML)May 21, 2014Biotech News - PR Newswire
AAA Receives Orphan Drug Designation from FDA and EMA for Gallium-68 DOTATATE for Use in Patients with Gastro-Entero-Pancreatic Neuroendocrine TumorsMarch 04, 2014Biotech News - PR Newswire
Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access IssuesFebruary 13, 2014Medical Pharma - PR Newswire
<b>Harvard Apparatus Regenerative Technology</b> Files Pre-IND Meeting Documents And Orphan Biologics Application With U.S. FDA January 06, 2014BioSpace - Breaking News
<b>DiaVacs's</b> Immunotherapy Product For Treatment Of Type 1 Diabetes Receives Orphan Drug Status Designation From The FDA January 06, 2014BioSpace - Breaking News
Harvard Apparatus Regenerative Technology Files Pre-IND Meeting Documents and Orphan Biologics Application with U.S. Food and Drug AdministrationJanuary 06, 2014Biotech News - Business Wire
Harvard Apparatus Regenerative Technology Files Pre-IND Meeting Documents and Orphan Biologics Application with U.S. Food and Drug AdministrationJanuary 06, 2014FDA News - Business Wire
DiaVacs's Immunotherapy Product for Treatment of Type 1 Diabetes Receives Orphan Drug Status Designation from the FDAJanuary 06, 2014Biotech News - PR Newswire
Scioderm Appoints Orphan Product Executives To Board Of Directors December 02, 2013BioSpace - Breaking News
Scioderm Appoints Orphan Product Executives to Board of DirectorsDecember 02, 2013Biotech News - PR Newswire
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency (EMA)November 11, 2013Biotech News - Business Wire
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency (EMA)November 11, 2013Pharma News - Business Wire
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency (EMA)November 11, 2013FDA News - Business Wire
Aduro Receives Orphan Drug Designation for CRS-207 for Pancreatic CancerOctober 22, 2013Pharma News - PharmiWeb
Aduro Receives Orphan Drug Designation for CRS-207 for Pancreatic CancerOctober 22, 2013Biotech News - Business Wire
Aduro Receives Orphan Drug Designation for CRS-207 for Pancreatic CancerOctober 22, 2013Pharma News - Business Wire
Aduro Receives Orphan Drug Designation for CRS-207 for Pancreatic CancerOctober 22, 2013FDA News - Business Wire
FDA Grants Orphan Drug Designation to Lipiodol® (Ethiodized Oil) Injection for Management of Patients with Known Hepatocellular Carcinoma (HCC)October 21, 2013Pharma News - PR Newswire
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's DiseaseSeptember 30, 2013Biotech News - PR Newswire
Zalicus Inc.??? Z160 Receives Orphan Drug Designation for the Management of Postherpetic Neuralgia September 27, 2013BioSpace - Breaking News
Zalicus’ Z160 Receives Orphan Drug Designation for the Management of Postherpetic NeuralgiaSeptember 27, 2013Pharma News - PharmiWeb
Zalicus gets orphan drug designation, stock hits 1-year highSeptember 27, 2013Health News - BizJournals.com
Zalicus’ Z160 Receives Orphan Drug Designation for the Management of Postherpetic NeuralgiaSeptember 27, 2013Biotech News - Business Wire
Zalicus’ Z160 Receives Orphan Drug Designation for the Management of Postherpetic NeuralgiaSeptember 27, 2013Pharma News - Business Wire
Zalicus’ Z160 Receives Orphan Drug Designation for the Management of Postherpetic NeuralgiaSeptember 27, 2013FDA News - Business Wire
Research and Markets: European Payers Push Back on Orphan Drug PricesSeptember 27, 2013Pharma News - Business Wire
Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver DiseasesSeptember 26, 2013Pharma News - PR Newswire
Bayer's Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary HypertensionSeptember 25, 2013Pharma News - PR Newswire
RARE Science Brings New Hope To Patients With Rare, Neglected and Orphan DiseasesSeptember 16, 2013Medical Pharma - PR Newswire
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation SyndromeSeptember 16, 2013Biotech News - PR Newswire
Versartis Receives Orphan Drug Status for Its Novel Long-Acting Growth Hormone Treatment From European CommissionSeptember 13, 2013Marketwire - Pharma and Biotech
Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDLSeptember 12, 2013Biotech News - PR Newswire
Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based Treatment for Retinitis PigmentosaSeptember 11, 2013Pharma News - PharmiWeb
Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based Treatment for Retinitis PigmentosaSeptember 11, 2013Biotech News - Business Wire
Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based Treatment for Retinitis PigmentosaSeptember 11, 2013Pharma News - Business Wire
Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based Treatment for Retinitis PigmentosaSeptember 11, 2013FDA News - Business Wire
BioLineRx Ltd.'s BL-8040 Receives Orphan Drug Designation for Treatment of AML September 09, 2013BioSpace - Breaking News
NovelMed Awarded NIH Fast Track SBIR Grant for $1.43 Million to Advance Development of its Anti-Complement Antibody for Orphan DiseaseSeptember 09, 2013Pharma News - PR Newswire
BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AMLSeptember 09, 2013Biotech News - PR Newswire
Orphan Drugs for Cancer: R&D and Market 2013-2023September 02, 2013Pharma News - PR Newswire
Research and Markets: Orphan Drugs Partnering Terms and Agreements - 2013 Featuring over 140 Orphan Drugs DealsAugust 29, 2013Pharma News - Business Wire
Bicoll GmbH Announces a Fast Small Molecule Ligand Validation Method for Orphan Targets August 29, 2013BioSpace - Breaking News
Alnylam gets orphan status for hemophilia AAugust 20, 2013Health News - BizJournals.com
Alnylam Pharmaceuticals Receives Additional Orphan Drug Designation From FDA for ALN-AT3, an RNAi Therapeutic for the Treatment of Hemophilia August 20, 2013BioSpace - Breaking News
Biotech rallies behind tax incentive for orphan drug research August 12, 2013FierceBiotech
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the US FDAAugust 12, 2013Pharma News - Business Wire
NanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the US FDAAugust 12, 2013FDA News - Business Wire
BioGaia: FDA approves BioGaia's request for orphan drug designationAugust 06, 2013Pharma News - Business Wire
Dicerna gets $60M to advance therapeutics targeting orphan diseasesAugust 01, 2013Health News - BizJournals.com
Top 20 orphan drugs by 2018July 23, 2013FiercePharma
ARMAGEN® Receives US Orphan Designation For Lead Product AGT-182July 18, 2013Biotech News - PR Newswire
Auxilium Pharmaceuticals, Swedish Orphan Biovitrum Hook Up for $40 Million+ Deal July 16, 2013BioSpace - Breaking News
Alexion’s Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)July 16, 2013Biotech News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)July 16, 2013Biotech News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)July 16, 2013Pharma News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)July 16, 2013Pharma News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)July 16, 2013FDA News - Business Wire
Auxilium Pharmaceuticals, Inc. And Swedish Orphan Biovitrum AB (publ) Enter A Collaboration Agreement For XIAPEX® In 71 Eurasian And African CountriesJuly 16, 2013Pharma News - PR Newswire
NanoViricides, Inc. Submits DengueCide&#0153; Orphan Drug Designation Letter of Intent to File With the European Medicines Agency July 01, 2013BioSpace - Breaking News
Dompe Announces the European Medicines Agency Has Granted Orphan Drug Designation to Its rhNGF-Based Treatment for Retinitis Pigmentosa July 01, 2013BioSpace - Breaking News
Dompé Announces the EMA Has Granted Orphan Drug Designation to Its rhNGF-Based Treatment for Retinitis PigmentosaJuly 01, 2013Pharma News - PharmiWeb
NanoViricides Submits DengueCide™ Orphan Drug Designation Letter of Intent to File with the European Medicines AgencyJuly 01, 2013Biotech News - Business Wire
Dompé Announces the EMA Has Granted Orphan Drug Designation to Its rhNGF-Based Treatment for Retinitis PigmentosaJuly 01, 2013Biotech News - Business Wire
Activartis’ Cancer Immunotherapy Receives Orphan Drug Designation from FDAJuly 01, 2013b3c newswire
An Orphan JackpotJune 30, 2013New York Times- Pharmaceuticals
The Orphan JackpotJune 30, 2013New York Times- Pharmaceuticals
Alexion’s Soliris® (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO)June 27, 2013Biotech News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO)June 27, 2013Pharma News - Business Wire
Alexion’s Soliris® (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO)June 27, 2013FDA News - Business Wire
Research and Markets: Pioneering Pharma Companies Benefit from Untapped Market of Acquired Orphan Blood Disease DrugsJune 26, 2013Biotech News - Business Wire
Research and Markets: Inherited Orphan Blood Diseases Patients Face Stagnant Treatment FutureJune 26, 2013Pharma News - Business Wire
Research and Markets: Pioneering Pharma Companies Benefit from Untapped Market of Acquired Orphan Blood Disease DrugsJune 26, 2013Pharma News - Business Wire
Orphan Drugs in Oncology Drug Pipeline Update 2013June 25, 2013Medical Pharma - PR Newswire
Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer with ADXS-HPVJune 24, 2013Biotech News - Business Wire
Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer with ADXS-HPVJune 24, 2013Pharma News - Business Wire
Charmed by orphan drugs, suitors line up for ViroPharmaJune 18, 2013FiercePharma
ViroPharma drug gets orphan designationJune 11, 2013Health News - BizJournals.com
Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Head and Neck Cancer with ADXS-HPVJune 11, 2013FDA News - Business Wire
ViroPharma Receives Orphan Drug Designation For Maribavir In EuropeJune 11, 2013Pharma News - PR Newswire
Advaxis, Inc. Requests Orphan Drug Designation for Treatment of Cervical Cancer With ADXS-HPV June 07, 2013BioSpace - Breaking News
Advaxis Requests Orphan Drug Designation for Treatment of Cervical Cancer with ADXS-HPVJune 07, 2013FDA News - Business Wire
OxThera Strengthens Patent Portfolio for Orphan Disease - Primary HyperoxaluriaJune 04, 2013Biotech News - PR Newswire
Jennerex, Inc. Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC) May 09, 2013BioSpace - Breaking News
EU-Zulassungsbehörden erteilen Lenvatinib von Eisai "Orphan Drug"-Status für die Behandlung von radiojod-refraktären differenzierten SchilddrüsenkarzinomenMay 06, 2013Biotech News - PR Newswire
Raptor's orphan drug-win at FDA overshadowed by debate over steep price May 01, 2013FierceBiotech
Worldwide Orphan Drug Market to Grow to $127 Billion by 2018April 23, 2013Biotech News - Business Wire
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402April 23, 2013Pharma News - Business Wire
Worldwide Orphan Drug Market to Grow to $127 Billion by 2018April 23, 2013Pharma News - Business Wire
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402April 23, 2013FDA News - Business Wire
Evaluate to Launch Orphan Drug Report at the 2013 BIO International ConventionApril 12, 2013Pharma News - PharmiWeb
<b>Evaluate</b> to Launch Orphan Drug Report at the 2013 Biotechnology Industry Organization (BIO) International Convention April 12, 2013BioSpace - Breaking News
Evaluate to Launch Orphan Drug Report at the 2013 BIO International ConventionApril 12, 2013Biotech News - Business Wire
Evaluate to Launch Orphan Drug Report at the 2013 BIO International ConventionApril 12, 2013Pharma News - Business Wire
Rare, orphan drug accelerator launches in Cambridge with $16MApril 11, 2013Health News - BizJournals.com
NEA leads $16m investment in orphan drug acceleratorApril 11, 2013Health News - BizJournals.com
Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate EquitiesApril 11, 2013Biotech News - Business Wire
Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate EquitiesApril 11, 2013Pharma News - Business Wire
Acceleron receives two orphan drug designations from FDAMarch 27, 2013Health News - BizJournals.com
Acceleron wins orphan status for ACE-536March 27, 2013FierceBiotech
Acceleron Receives Two FDA Orphan Designations for ACE-536March 26, 2013Biotech News - Business Wire
Acceleron Receives Two FDA Orphan Designations for ACE-536March 26, 2013Pharma News - Business Wire
Acceleron Receives Two FDA Orphan Designations for ACE-536March 26, 2013FDA News - Business Wire
GenSpera receives orphan drug designation from FDA for treatment of carcinomaMarch 14, 2013Health News - BizJournals.com
GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular CarcinomaMarch 14, 2013Pharma News - PharmiWeb
GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular CarcinomaMarch 14, 2013Pharma News - Business Wire
GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular CarcinomaMarch 14, 2013FDA News - Business Wire
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing PotentialMarch 04, 2013Biotech News - PR Newswire
Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan DiseaseFebruary 26, 2013Pharma News - PharmiWeb
Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan DiseaseFebruary 26, 2013Clinical Trials - Business Wire
Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan DiseaseFebruary 26, 2013Biotech News - Business Wire
Psyadon Pharmaceuticals, Inc. Announces First Patients Enrolled in Phase 3 Study of Ecopipam for the Orphan Indication Lesch-Nyhan DiseaseFebruary 26, 2013Pharma News - Business Wire
Research and Markets: Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet NeedFebruary 04, 2013Pharma News - Business Wire
Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.comJanuary 29, 2013Pharma News - PharmiWeb
Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.comJanuary 29, 2013Biotech News - Business Wire
Inherited Orphan Blood Disorders Therapeutics Market Examined in New GBI Research Report Recently Published at MarketPublishers.comJanuary 29, 2013Pharma News - Business Wire
Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet NeedJanuary 29, 2013Pharma News - PR Newswire
Research and Markets: Orphan Drugs: Market Environment Products and CompaniesJanuary 16, 2013Pharma News - PharmiWeb
Research and Markets: Orphan Drugs: Market Environment Products and CompaniesJanuary 16, 2013Pharma News - Business Wire
Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic SyndromeJanuary 12, 2013Biotech News - PR Newswire
<b>Proteo, Inc. / Proteo Biotech AG</b>: FDA Grants <b>Proteo</b> Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension January 10, 2013BioSpace - Breaking News
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertensionJanuary 10, 2013Pharma News - PharmiWeb
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertensionJanuary 10, 2013Clinical Trials - Business Wire
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertensionJanuary 10, 2013Biotech News - Business Wire
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertensionJanuary 10, 2013Pharma News - Business Wire
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertensionJanuary 10, 2013FDA News - Business Wire
FDA Approves Swedish Orphan Biovitrum's Kineret for the Treatment of NOMID January 08, 2013BioSpace - Breaking News
Shire gambles on one-man biotech startup to gain ultra-orphan drugJanuary 08, 2013FierceBiotech
FDA advisers back NPS Pharma's orphan bowel drugOctober 16, 2012FierceBiotech
Research and Markets: Raptor's RP 103 for Nephropathic Cystinosis - an Orphan Genetic DiseaseOctober 15, 2012Pharma News - Business Wire
Cell Therapeutics rises on orphan drug decisionOctober 02, 2012Health News - CNBC
Endocyte, Inc. Granted Orphan Drug Status for Folic Acid by European Commission (EC) September 27, 2012BioSpace - Breaking News
Depomed sues FDA over 'additional hurdles' to orphan exclusivitySeptember 27, 2012FiercePharma
Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise® (Gabapentin)September 25, 2012Pharma News - PR Newswire
Omeros Awarded NIMH Grant for Development of Orphan GPCR AntibodiesSeptember 19, 2012Medical Pharma - PR Newswire
EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh SyndromeSeptember 12, 2012Pharma News - PR Newswire
Cerus to Partner with American Red Cross and Blood Systems Incorporated to Commercialize INTERCEPT Plasma for Thrombotic Thrombocytopenic Purpura (TTP) Orphan IndicationSeptember 11, 2012FDA News - Business Wire
UPDATED: Pfizer wins FDA approval for orphan chronic myelogenous leukemia drug September 04, 2012FierceBiotech
FDA approves new orphan drug for chronic myelogenous leukemiaSeptember 04, 2012FDA Press Releases
Aerial BioPharma Receives FDA Orphan Drug Designation for Narcolepsy Drug in DevelopmentAugust 29, 2012Pharma News - Business Wire
Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients August 16, 2012BioSpace
Pharmalucence Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma PatientsAugust 16, 2012FDA News - Business Wire
Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRsAugust 15, 2012Biotech News - PR Newswire
Senesco’s Lead Therapeutic Candidate, SNS01-T, Granted Orphan Drug Status from FDA for Treatment of Mantle Cell Lymphoma and Diffuse Large B-Cell LymphomaJuly 30, 2012Pharma News - Business Wire
Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant MelanomaJuly 24, 2012b3c newswire
Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver DiseasesJuly 24, 2012Biotech News - PR Newswire
PTC investors back lead orphan drug with $30M roundJuly 23, 2012FierceBiotech
Hemispherx seeks orphan status in Argentina for chronic fatigue drugJuly 18, 2012Health News - BizJournals.com
<b>European Commission</b> Grants Orphan Medicinal Product Designation for Emmaus Medical, Inc.'s Sickle Cell Treatment July 17, 2012BioSpace - Breaking News
Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic FibrosisJuly 17, 2012Pharma News - PR Newswire
European Commission Grants Orphan Medicinal Product Designation for Emmaus Medical's Sickle Cell TreatmentJuly 17, 2012Pharma News - PharmiWeb
Swedish Orphan Biovitrum Enters Research Collaboration With Affibody Within the IL-1 Field July 10, 2012BioSpace - Breaking News
Cytheris SA Announces CYT107 Orphan Drug Designation in Europe for the Treatment of Progressive Multifocal Leucoencephalopathy (PML) July 10, 2012BioSpace - Breaking News
Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington's Disease SegmentJune 28, 2012Medical Pharma - PR Newswire
Research and Markets: Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision MakingJune 27, 2012Pharma News - Business Wire
Medgenics Receives Orphan Drug Designation from FDA for INFRADURE Biopump to Treat Hepatitis DJune 20, 2012FDA News - Business Wire
Alnylam Pharmaceuticals Gets Orphan Status for Neurodegenerative Disease Drug June 20, 2012BioSpace
Stratatech’s StrataGraft® Skin Substitute Granted FDA Orphan Drug DesignationJune 13, 2012FDA News - Business Wire
ERYTECH Pharma’s Sickle Cell Treatment Receives Positive Opinion for Orphan Drug Designation from the European Medicines AgencyJune 13, 2012Pharma News - Business Wire
FDA Issues Orphan Status Approval for PermaDerm®June 12, 2012Biotech News - PR Newswire
NORD Calls Senate Bill Most Important Since Orphan Drug ActMay 24, 2012Pharma News - PR Newswire
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing ActivityMay 23, 2012Medical Pharma - PR Newswire
Research and Markets: Orphan Disease Therapeutics Market to 2018 - Big Pharma to Target Orphan DiseasesMay 22, 2012Pharma News - Business Wire
Market Research Forecasts Oncology Orphan Disease Market at $6.4 Billion by 2018May 22, 2012Marketwire - Pharma and Biotech
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster InnovationMay 10, 2012Medical Pharma - PR Newswire
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage MoleculesMay 10, 2012Medical Pharma - PR Newswire
Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis DApril 23, 2012FDA News - Business Wire
BioAlliance Pharma Announces: New Achievements in Clonidine Lauriad™ Clinical Development, Second Product of Its Orphan Oncology PortfolioApril 17, 2012Pharma News - Business Wire
REGENX Biosciences, LLC Receives FDA Orphan Designation for Treatment of Familial Hypercholesterolemia Using NAV(TM) rAAV8 Vectors April 10, 2012BioSpace - Breaking News
REGENX BioSciences Receives FDA Orphan Designation for Treatment of Familial Hypercholesterolemia Using NAV(TM) rAAV8 VectorsApril 10, 2012Marketwire - Pharma and Biotech
FDA gives Threshold's TH-302 orphan drug statusMarch 30, 2012Health News - CNBC
Swedish Orphan Biovitrum Amends its Agreement With Sellers of Arexis AB March 30, 2012BioSpace - Breaking News
Threshold Pharmaceuticals, Inc.'s Cancer Drug Gets FDA Orphan Status, Shares Rise March 30, 2012BioSpace
Threshold cancer drug gets orphan status in U.S.March 30, 2012Health News - CNBC
Threshold's cancer drug gets FDA orphan status, shares riseMarch 30, 2012Health News - CNBC
Threshold Pharmaceuticals Receives US Orphan Drug Designation for TH-302 for the Treatment of Soft Tissue SarcomaMarch 30, 2012Marketwire - Pharma and Biotech
FDA Grants Orphan Status to Lexicon Pharmaceuticals, Inc. Cancer Drug March 21, 2012BioSpace - Breaking News
FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid SyndromeMarch 20, 2012Biotech News - PR Newswire
Threshold Pharmaceuticals, Inc.' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma March 16, 2012BioSpace - Breaking News
Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue SarcomaMarch 16, 2012Marketwire - Pharma and Biotech
Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)March 07, 2012FDA News - Business Wire
4s3 Raises $20M to Create Protein Therapies for Orphan Neuromuscular DisordersMarch 06, 2012Inside Industry - Gen
Cytokinetics, Inc. Announces That the European Medicines Evaluation Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis March 06, 2012BioSpace - Breaking News
Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Disorders of the Nervous SystemFebruary 29, 2012Biotech News - PR Newswire
Adding Six More, Omeros Now Has a Total of 33 Unlocked Orphan GPCRs in its PortfolioFebruary 29, 2012Medical Pharma - PR Newswire
Ultragenyx lands orphan designation for 2nd drugFebruary 28, 2012Health News - BizJournals.com
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharmaFebruary 23, 2012FDA News - Business Wire
Omeros Announces It Has Unlocked 35 Percent of Class A Orphan GPCRsFebruary 23, 2012Biotech News - PR Newswire
Syria's 'orphan revolution'February 20, 2012CNN Top Stories
CSL hemophilia treatment gets orphan drug status in U.S.February 16, 2012Health News - BizJournals.com
ReFacto AF(R)/XYNTHA(R) Supply Agreement Extended Until 2020 for Swedish Orphan Biovitrum and Pfizer Inc. February 16, 2012BioSpace - Breaking News
CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have InhibitorsFebruary 16, 2012Pharma News - PR Newswire
Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and EclampsiaFebruary 14, 2012Pharma News - PR Newswire
Swedish Orphan Biovitrum's Agreement With Biogen Idec, Inc. (Massachusetts) Regarding Long-Lasting rFVIIIFc and rFIXFc Hemophilia Programs February 06, 2012BioSpace
BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne™ Leukemia VaccineFebruary 06, 2012Pharma News - PR Newswire
Del Mar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of GliomaFebruary 02, 2012Marketwire - Pharma and Biotech
European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's Acute Myeloid Leukemia VaccineFebruary 01, 2012Pharma News - PharmiWeb
European Medicines Evaluation Agency Approves Orphan Medicinal Product Application of Acute Myeloid Leukemia Vaccine February 01, 2012BioSpace - Breaking News
BioMarin aims to scoop up rare disease drugs as orphan field sizzlesJanuary 27, 2012FierceBiotech
Celator Pharmaceuticals, Inc. Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia January 26, 2012BioSpace - Breaking News
Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid LeukemiaJanuary 26, 2012FDA News - Business Wire
FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial HypertensionJanuary 23, 2012Pharma News - PR Newswire
Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical Drugs with Orphan Drug Exclusivity Granted by the FDA (BIZ)January 19, 2012Pharmaceutical - Moreover
Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical...January 19, 2012Pharmaceutical - Moreover
Research and Markets: Orphan Drug Report 2012 Profiles the Pharmaceutical Drugs with Orphan Drug Exclusivity Granted by the FDAJanuary 19, 2012FDA News - Business Wire
Ceptaris cutaneous T-cell lymphoma drug gets Europe orphan statusJanuary 18, 2012Health News - BizJournals.com
Ceptaris Therapeutics, Inc. Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel January 18, 2012BioSpace - Breaking News
Orphan Drug Markets in Europe: Key Developments and the Strategies of Major Pharmaceutical CompaniesJanuary 18, 2012Pharmaceutical - Moreover
Ceptaris Therapeutics Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine GelJanuary 18, 2012Pharma News - Business Wire
Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRsJanuary 10, 2012Biotech News - PR Newswire
AiCuris Receives Orphan Drug Designation for Letermovir (AIC246) from FDAJanuary 05, 2012b3c newswire
EMA Grants Orphan Drug Status to NovaBiotics LynovexJanuary 05, 2012Biotechnology - Moreover
Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular DystrophyJanuary 04, 2012Biotech News - PR Newswire
FDA Grants Orphan Drug Status to Spectrum Pharmaceuticals' Fusilev [Health & Beauty Close - Up]December 14, 2011Biotechnology - Moreover
Treatment of Patients With Malignant Mesothelioma Utilizing Photodynamic Therapy With Pinnacle Biologics' Compound PHOTOFRIN® - Obtains FDA Orphan Drug DesignationDecember 14, 2011Biotech News - PR Newswire
Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain CancerDecember 12, 2011Biotech News - PR Newswire
Number of Orphan Medicines to Grow in Europe as 'Big Pharma' Takes an Interest Says New Report from URCH PublishingDecember 09, 2011Pharmaceutical - Moreover
Number of Orphan Medicines to Grow in Europe as ‘Big Pharma’ Takes an Interest Says New Report from URCH PublishingDecember 09, 2011Pharma News - Business Wire
S.L.A. Pharma Announce Phase III Orphan Drug Program for FAPDecember 08, 2011Pharma News - PharmiWeb
Avedro Announces Its Second FDA Orphan Drug Designation for Corneal Cross-linkingDecember 07, 2011FDA News - Business Wire
Médunik Canada to help Canadians with rare diseases with two new orphan therapiesNovember 29, 2011Pharmaceutical - Moreover
Mdunik Canada to help Canadians with rare diseases with two new orphan therapiesNovember 29, 2011Pharmaceutical - Moreover
M�dunik Canada to help Canadians with rare diseases with two new orphan therapies (CNW)November 29, 2011Pharmaceutical - Moreover
Médunik Canada to help Canadians with rare diseases with two new orphan therapiesNovember 29, 2011Biotech News - PR Newswire
Hanmi applies for orphan drug designation for LAPS-rhGHNovember 28, 2011Pharmaceutical - Moreover
Research and Markets: Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in OncologyNovember 14, 2011Clinical Trials - Business Wire
Santen Announces FDA Orphan Drug Status for Sirolimus (DE-109)November 10, 2011Pharma News - Business Wire
DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal InsufficiencyNovember 07, 2011Pharma News - PR Newswire
Genome of 'orphan crop' pigeonpea crackedNovember 07, 2011Biotechnology - Moreover
BioAlliance Pharma Announces: Grant of Orphan Designation for clonidine Lauriad??? in Europe November 03, 2011BioSpace - Breaking News
Clinuvel Announces Positive Results of First Phase II US Study of SCENESSE?? in Orphan Disease erythropoietic protoporphyria (EPP) November 03, 2011BioSpace - Breaking News
Discovery Lab’s cystic fibrosis treatment gets Europe orphan status November 03, 2011Health News - BizJournals.com
Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria (EPP)November 03, 2011Pharma News - Business Wire
Biotechnology Industry Organization (BIO) Announces: Grant of Orphan Designation for Clonidine Lauriad(TM) in EuropeNovember 02, 2011Biotechnology - Moreover
Celldex Therapeutics, Inc. Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for Glioblastoma October 31, 2011BioSpace - Breaking News
Celldex Therapeutics Announces Orphan Drug Designation in the European Union for Rindopepimut, a Novel EGFRvIII Vaccine for GlioblastomaOctober 31, 2011FDA News - Business Wire
ViroPharma inks $164M deal to buy orphan drug biotech October 27, 2011FierceBiotech
ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial PipelineOctober 27, 2011Biotech News - PR Newswire
Atox Bio Granted Orphan Drug Designation for AB103 for the Treatment of Necrotizing Soft Tissue Infections (NSTI).October 25, 2011FDA News - Business Wire
Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma.October 24, 2011Biotech News - PR Newswire
Swedish Orphan Biovitrum AB (publ): Interim Report January - September, 2011October 20, 2011Marketwire - Pharma and Biotech
4SC AG's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat Hodgkin's Lymphoma October 13, 2011BioSpace - Breaking News
4SC's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat Hodgkin's LymphomaOctober 13, 2011Pharma News - Business Wire
4SCs Anti-Tumor-Wirkstoff Resminostat erhält in Indikation Hodgkin Lymphom Empfehlung zur Einstufung als 'Orphan Medicinal Product' in EuropaOctober 13, 2011Pharma News - Business Wire
Orphan Drug SpecialistOctober 12, 2011Pharmaceutical - Moreover
Study: Orphan drugs win favored status in FDA reviewsOctober 12, 2011FierceBiotech
OctreoPharm Sciences Receives Orphan Drug Designation for SOMscan® for the Diagnosis of Neuroendocrine TumoursOctober 12, 2011Biotech News - PR Newswire
Cost of orphan drugs to EU 'sustainable until 2020' Friday 7th October 2011October 11, 2011Pharmaceutical - Moreover
Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body MyopathyOctober 08, 2011Pharmaceutical - Moreover
Orphan drugs cost likely to be sustainable to European health budgets in the next 10 years, new research showsOctober 07, 2011Pharmaceutical - Moreover
Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM)October 05, 2011Biotech News - PR Newswire
Head of R&D to leave Swedish Orphan Biovitrum October 04, 2011BioSpace - Breaking News
Tarix Pharmaceuticals' TXA127 Granted Orphan Drug Status for Treatment of Pulmonary Arterial Hypertension September 27, 2011BioSpace - Breaking News
Aeolus files Orphan Drug Designation application for AEOL 10150September 26, 2011Biotechnology - Moreover
4SC's Resminostat receives FDA Orphan Drug Status for Hodgkin's LymphomaSeptember 26, 2011Pharma News - Business Wire
Aeolus Pharma Files Request For Orphan Drug Designation Of AEOL 10150September 23, 2011Biotechnology - Moreover
Aeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Effects of Acute Radiation Exposure of the LungSeptember 23, 2011Marketwire - Pharma and Biotech
Dove Medical Press Announces Dr Lise Aagaard as the Editor-in-Chief of Orphan Drugs: Research and ReviewsSeptember 21, 2011Pharmaceutical - Moreover
DIA/FDA Orphan Drug Designation One-Day WorkshopSeptember 20, 2011Biotechnology - Moreover
DIA and NORD Host First Conference to Address All Aspects of Orphan Product DevelopmentSeptember 15, 2011Biotechnology - Moreover
CEL-SCI’s Taiwanese Partner Orient Europharma Presents Development Strategies in Taiwan for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) at World Orphan Drug Conference Today in Seoul, KoreaSeptember 15, 2011Biotech News - Business Wire
NORD and DIA to Host Conference on Rare Diseases and Orphan ProductsSeptember 14, 2011Pharma News - PR Newswire
Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant September 14, 2011BioSpace - Breaking News
Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune™ Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow TransplantSeptember 14, 2011FDA News - Business Wire
Omeros announces unlocking four additional Orphan GPCRsSeptember 14, 2011Pharmaceutical - Moreover
Uveitis drug granted EU orphan statusSeptember 14, 2011Pharmaceutical - Moreover
Centric Health Resources Annual Conference Addresses Concerns of Ultra Orphan Patient Populations Speakers include Kenneth J. Tomaszewski, KJT Group; Michael McCaughan, Prevision Policy, LLC; Molly Stuart, International Pemphigus and Pemphigoid FoundatioSeptember 13, 2011Pharmaceutical - Moreover
Centric Health Resources Annual Conference Addresses Concerns of Ultra Orphan Patient PopulationsSeptember 13, 2011Pharma News - Business Wire
Omeros Unlocks Four Additional Orphan GPCRsSeptember 13, 2011Biotech News - PR Newswire
Avedro VibeX gets FDA orphan drug statusSeptember 13, 2011Pharmaceutical - Moreover
Avedro, Inc. Announces FDA Orphan Drug Designation for Its Corneal Cross-linking September 12, 2011BioSpace - Breaking News
Avedro Announces FDA Orphan Drug Designation for Its Corneal Cross-linkingSeptember 12, 2011FDA News - Business Wire
DIA / FDA Orphan Drug Designation WorkshopSeptember 10, 2011Biotechnology - Moreover
Santen, Inc. Announces European Medicines Evaluation Agency Orphan Drug Status for Sirolimus (DE-109) September 08, 2011BioSpace - Breaking News
EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitisSeptember 08, 2011Pharmaceutical - Moreover
Santen sirolimus gets EC orphan drug statusSeptember 08, 2011Pharmaceutical - Moreover
Santen Announces EMA Orphan Drug Status for Sirolimus (DE-109)September 08, 2011Pharma News - Business Wire
OPKO Health Announces Grant from Penn Center for Orphan Disease Research and TherapySeptember 06, 2011Biotech News - Business Wire
Mitsubishi Tanabe Pharma taps Synageva for orphan disease R&D September 02, 2011FierceBiotech
NPS Re-Jiggers Glaxo Partnership, Finds Value in Ultra-Orphan DiseasesAugust 09, 2011Xconomy Life Sciences
US Conference on Rare Diseases and Orphan ProductsAugust 08, 2011Biotechnology - Moreover
Kamada Ltd. Was Granted New Orphan Drug Designation by the FDA for the Treatment of Type 1 Diabetes August 04, 2011BioSpace - Breaking News
Kamada Ltd. Was Granted New Orphan Drug Designation by the FDA, for the Treatment of Type 1 Diabetes August 04, 2011BioSpace - Breaking News
Kamada Was Granted New Orphan Drug Designation by the FDA, for the Treatment of Type 1 DiabetesAugust 04, 2011Pharma News - Business Wire
Swedish Orphan Biovitrum Release: First Patient Enrolled in the Kiobrina(R) Phase III Study August 02, 2011BioSpace - Breaking News
FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic CancerAugust 01, 2011Biotech News - PR Newswire
Q2 2011: BioAlliance Pharma Accelerates the Progress of Its “Orphan Oncology Products” Portfolio and Pursues Its International Partnerships on Its “Specialty Products”July 28, 2011Pharma News - Business Wire
Penn erhält $10 Millionen zur Gründung eines Forschung- und Therapiezentrums für Orphan DiseasesJuly 27, 2011Biotech News - PR Newswire
Penn medical school to create orphan drug center with $10M giftJuly 26, 2011Health News - BizJournals.com
Penn Receives $10 Million to Create Center for Orphan Disease Research and TherapyJuly 26, 2011Biotech News - PR Newswire
Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting July 26, 2011BioSpace - Breaking News
Biogen Idec, Inc. (California) and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at Meeting July 26, 2011BioSpace - Breaking News
FDA Grants s TM-400 Orphan Drug Designation for Mobilization of Stem Cells Used to Treat Hematologic Cancer in the U.S. July 26, 2011BioSpace - Breaking News
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain CancerJuly 26, 2011FDA News - Business Wire
Samenvatting: Biogen Idec en Swedish Orphan Biovitrum presenteren gegevens van behandeling met langdurig werkzame recombinante factor VIII tijdens bijeenkomst van internationale vereniging voor trombose en hemostaseJuly 26, 2011Pharma News - Business Wire
Resumen: Biogen Idec y Swedish Orphan Biovitrum presentan datos sobre tratamiento del factor VIII recombinante con acción duradera en la reunión de la International Society sobre trombosis y hemostasiaJuly 26, 2011Pharma News - Business Wire
Biogen Idec und Swedish Orphan Biovitrum legen Daten zur Therapie mit dem langwirkenden rekombinanten Faktor VIII auf der Tagung der International Society on Thrombosis and Haemostasis vorJuly 26, 2011Pharma News - Business Wire
Biogen Idec et Swedish Orphan Biovitrum présentent des résultats sur le traitement avec le facteur VIII recombinant à action prolongée à l'occasion de la réunion de la Société internationale de thrombose et d'hémostaseJuly 26, 2011Pharma News - Business Wire
FDA Grants TM-400 Orphan Drug Designation for Mobilization of Stem Cells Used to Treat Hematologic Cancer in the U.S.July 26, 2011FDA News - Business Wire
European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC's Resminostat to Treat Hepatocellular CarcinomaJuly 26, 2011Pharma News - Business Wire
Europäische Arzneimittelagentur EMA empfiehlt Einstufung des 4SC-Wirkstoffs Resminostat als 'Orphan Medicinal Product' zur Behandlung des hepatozellulären KarzinomsJuly 26, 2011Pharma News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis MeetingJuly 26, 2011Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum presentano dati sulla terapia di lunga durata con fattore VIII ricombinante alla riunione dell'International Society on Thrombosis and HaemostasisJuly 26, 2011Pharma News - Business Wire
FDA's Coté, Director Of Orphan Products Development Office, Jumps To NORDJuly 20, 2011Pharmaceutical - Moreover
Swedish Orphan Biovitrum: Interim Report January - June 2011July 19, 2011Marketwire - Pharma and Biotech
Notice at extraordinary general meeting in Swedish Orphan Biovitrum AB (publ)July 19, 2011Marketwire - Pharma and Biotech
Nektar Therapeutics (CA)'s NKTR-102 Receives Positive Opinion From European Medicines Evaluation Agency COMP for Orphan Medicinal Product Designation in Ovarian Cancer July 18, 2011BioSpace - Breaking News
NKTR-102 Receives Positive Opinion From EMA COMP for Orphan Medicinal Product Designation in Ovarian CancerJuly 18, 2011Pharma News - PR Newswire
FDA Grants Orphan Drug Designation to 4SC AG's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma July 12, 2011BioSpace - Breaking News
FDA Grants Orphan Drug Designation to 4SC's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular CarcinomaJuly 12, 2011FDA News - Business Wire
FDA erteilt 'Orphan Drug'-Status für den oralen Pan-HDAC-Inhibitor Resminostat von 4SC zur Behandlung des hepatozellulären KarzinomsJuly 12, 2011FDA News - Business Wire
Report: FDA Should Improve Approval Pathway for Orphan Drugs July 07, 2011BioSpace
CytRx Corporation (CYTR) Receives FDA Orphan Drug Designation for INNO-206 for the Treatment of Soft Tissue SarcomasJuly 06, 2011Biotechnology - Moreover
Centric Health Resources Sponsors Fourth Annual Conference to Address Needs of Ultra Orphan Patients and Strategies for Delivering Value OutcomesJuly 06, 2011Pharma News - Business Wire
CytRx Receives FDA Orphan Drug Designation for INNO-206 for the Treatment of Soft Tissue SarcomasJuly 05, 2011FDA News - Business Wire
Orphan drug status received in EU for PI-88: ProgenJune 30, 2011Biotechnology - Moreover
Swedish Orphan Biovitrum AB (publ): Extraordinary General Meeting to decide on share program for new CEOJune 30, 2011Marketwire - Pharma and Biotech
Swedish Orphan Biovitrum: Change in agreement regarding additional purchase consideration for Multiferon(R)June 30, 2011Marketwire - Pharma and Biotech
Geoffrey McDonough appointed President and CEO of Swedish Orphan BiovitrumJune 27, 2011Biotechnology - Moreover
ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardt's DiseaseJune 27, 2011Biotech News - PR Newswire
Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep DisordersJune 27, 2011Pharma News - PR Newswire
BioAlliance Pharma Submits Application for Orphan Medicinal Product Designation for Clonidine Lauriad™ in Europe and the United StatesJune 24, 2011Pharma News - Business Wire
Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia June 23, 2011BioSpace - Breaking News
Repligen Corporation Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy June 23, 2011BioSpace - Breaking News
Genetic Finding Offers Hope for Orphan Disease, Chuvash Polycythemia, Study June 23, 2011BioSpace
Accentia Biopharmaceuticals Announces that FDA grants Orphan Drug Status for Revimmune™ Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic AnemiaJune 23, 2011FDA News - Business Wire
Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular AtrophyJune 23, 2011FDA News - Business Wire
<b>Geoffrey McDonough</b> Appointed President and CEO of Swedish Orphan Biovitrum June 22, 2011BioSpace - Breaking News
Ultragenyx Raises $45M in Series A to Progress Lead Orphan Disease Candidate into ClinicJune 20, 2011Inside Industry - Gen
German biotech calls for fair treatment of orphan drugsJune 17, 2011Biotechnology - Moreover
Lamellar happy to win orphan statusJune 17, 2011Pharmaceutical - Moreover
Lamellar Biomedical Secures its First Orphan Drug LicenceJune 16, 2011b3c newswire
Research and Markets: Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues - 2011 EditionJune 16, 2011Pharma News - Business Wire
CytRx Receives Orphan Drug Status For Pancreatic Cancer, Unigene Labs Enters Into Termination Agreement.June 14, 2011Biotechnology - Moreover
US FDA grants orphan drug designation to Tengion's Neo-Urinary ConduitJune 13, 2011Biotechnology - Moreover
FDA gives orphan drug status to Tengion Neo-Urinary ConduitJune 10, 2011Biotechnology - Moreover
Morphotek Inc. Announces That Two Investigational Drugs Have Received Orphan Drug DesignationsJune 08, 2011Pharmaceutical - Moreover
Edison Pharmaceuticals, Inc. Announces FDA Grants EPI-743 Orphan Drug Designation June 08, 2011BioSpace - Breaking News
Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug DesignationsJune 08, 2011Pharma News - PR Newswire
Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug DesignationJune 08, 2011Pharma News - PR Newswire
Mobius Therapeutics(TM) Granted Orphan Drug Designation for Refractive IndicationsJune 06, 2011Marketwire - Pharma and Biotech
Aradigm Receives FDA Orphan Drug Designation for Ciprofloxacin for Inhalation in BronchiectasisJune 06, 2011FDA News - Business Wire
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple MyelomaJune 01, 2011Biotech News - PR Newswire
Omeros Corporation Unlocks Orphan GPCR Family Linked to Metabolic and Psychotic Disorders May 31, 2011BioSpace - Breaking News
CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B TreatmentMay 31, 2011Pharma News - PharmiWeb
YM BioSciences Announces Orphan Drug Designation for JAK1/JAK2 Inhibitor CYT387 in EuropeMay 31, 2011Clinical Trials - PR Newswire
Omeros Unlocks Orphan GPCR Family Linked to Metabolic and Psychotic DisordersMay 31, 2011Pharma News - PR Newswire
DIA/ FDA Orphan Drug Designation WorkshopMay 23, 2011Biotechnology - Moreover
Reportlinker Adds Orphan Drugs in Asia 2011May 23, 2011Medical Pharma - PR Newswire
Research and Markets: Amyotrophic Lateral Sclerosis - Orphan Status, Unmet Need, and Diverse Drug Targets Offer Opportunities for Drug Developers in United StatesMay 19, 2011Pharma News - Business Wire
Cytonet’s liver cell therapy granted orphan drug designationMay 18, 2011Biotechnology - Moreover
Orphan Europe Recordati S.p.A Receives 2011 Corporate Award From the May 18, 2011BioSpace - Breaking News
Orphan Europe (Recordati Group) Receives 2011 Corporate Award From the National Organization for Rare Disorders (NORD)May 18, 2011Marketwire - Pharma and Biotech
Swiss Mondobiotech's drug candidate gets orphan designation in USAMay 18, 2011Biotechnology - Moreover
Cytonet's Liver Cell Therapy Awarded Orphan Drug Designation for the Treatment of Urea Cycle DisordersMay 17, 2011Biotech News - PR Newswire
FDA Grants Orphan Drug Designation for Mithridion, Inc.'s MCD-386CR to Treat Progressive Supranuclear Palsy May 09, 2011BioSpace - Breaking News
Biogen Idec et Swedish Orphan Biovitrum reçoivent un avis favorable de l'EMA pour leur programme pédiatrique destiné à la thérapie à action prolongée pour l'hémophilie BMay 09, 2011Pharma News - Business Wire
Resumen: Biogen Idec y Swedish Orphan Biovitrum reciben opinión positiva de la EMA sobre plan pediátrico para terapia para la hemofilia B de larga duraciónMay 09, 2011Pharma News - Business Wire
Biogen Idec und Swedish Orphan Biovitrum erhalten EMA-Stellungnahme zu pädiatrischem Untersuchungsplan für lang wirkende Hämophilie-B-TherapieMay 09, 2011Pharma News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Receive Opinion from EMA on Pediatric Plan for Long-Lasting Hemophilia B TherapyMay 09, 2011Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum ricevono il parere dell'EMA sul progetto pediatrico di terapia a lungo termine per l'emofilia BMay 09, 2011Pharma News - Business Wire
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear PalsyMay 09, 2011Pharma News - PR Newswire
CytRx Corporation???s INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic Cancer April 28, 2011BioSpace - Breaking News
CytRx’s INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic CancerApril 28, 2011FDA News - Business Wire
Provectus Pharmaceuticals Inc. Receives Orphan Drug Designation from FDA for the Treatment of Liver Cancer April 27, 2011BioSpace
Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011April 27, 2011Pharma News - PR Newswire
Provectus Receives Orphan Drug Designation from FDA for the Treatment of Liver CancerApril 26, 2011FDA News - Business Wire
Nektar ovarian cancer drug gets FDA orphan statusApril 21, 2011Health News - BizJournals.com
AiCuris Receives Orphan Drug Designation for its Innovative Phase II Drug AIC246 for the Prevention of HCMV Disease April 21, 2011BioSpace - Breaking News
FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian CancerApril 21, 2011Pharma News - PR Newswire
Research and Markets: Orphan Drugs: Strategic Approaches for the Industry 2011April 21, 2011Pharma News - Business Wire
FDA Grants Orphan Drug Designation For Nektar Therapeutics (AL)'s Investigational Drug (NKTR) April 21, 2011BioSpace
AiCuris Receives Orphan Drug Designation for its Innovative Phase II Drug AIC246 for the ...April 21, 2011b3c newswire
Amira Drug Gets Orphan StatusApril 20, 2011Xconomy Life Sciences
Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary FibrosisApril 19, 2011Pharma News - PR Newswire
Research and Markets: Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011April 08, 2011Pharma News - Business Wire
FDA approves orphan drug vandetanibApril 07, 2011Pharma News - PharmiWeb
Zacharon Nabs $210M Deal With Pfizer to Tackle Orphan DiseasesApril 07, 2011Xconomy Life Sciences
Pfizer inks $210M orphan drug discovery pact with ZacharonApril 07, 2011FierceBiotech
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid CancerApril 06, 2011Pharma News - Business Wire
FDA Refuses to File Pfizer’s NDA for Orphan Drug TafamidisApril 04, 2011Inside Industry - Gen
America Stem Cell, Inc. Receives Orphan Drug Designation for ASC-1March 30, 2011Biotechnology - Moreover
America Stem Cell, Inc. Receives Orphan Drug Designation for ASC-101March 30, 2011FDA News - Business Wire
Indian Companys Drug to Get Orphan Drug Status by US FDAMarch 29, 2011Pharmaceutical - Moreover
Skinvisible, Inc. Submits Invisicare Formulation for FDA Orphan Drug Designation March 23, 2011BioSpace - Breaking News
Orphan Drugs Warrant Flexibility On Clinical Pharmacology Data, FDA Panel SaysMarch 21, 2011Pharmaceutical - Moreover
FDA Grants 'Orphan Drug' Status to Aegerion Pharmaceuticals, Inc. Drug March 16, 2011BioSpace
FDA Grants Orphan Drug Designation to Aegerion Pharmaceuticals, Inc.' Drug Candidate, Lomitapide, for Treatment of Familial Chylomicronemia March 15, 2011BioSpace - Breaking News
FDA grants 'orphan drug' status to Aegerion drugMarch 15, 2011Health News - CNBC
Cytonet: Leberzelltherapie erhält orphan drug-Status in USAMarch 15, 2011Pharma News - Business Wire
Advanced Cell Technology Receives Positive Opinion for Orphan Drug Designation from European Medicines Evaluation Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease March 10, 2011BioSpace - Breaking News
ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's DiseaseMarch 10, 2011Biotech News - PR Newswire
Research and Markets: The Orphan Drug Report 2011 is Essential Reading for those Operating inside the Pharma IndustryMarch 10, 2011Pharma News - PharmiWeb
BiovaxID gets EMA orphan statusMarch 09, 2011FierceVaccines
Stemline Therapeutics, Inc. Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid Leukemia March 09, 2011BioSpace - Breaking News
Stemline AML Drug Gains Orphan StatusMarch 09, 2011Contract Pharma
Stemline Therapeutics Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid LeukemiaMarch 09, 2011Clinical Trials - PR Newswire
Vanda Pharmaceuticals, Inc. Receives Orphan Drug Designation in Europe for tasimelteon March 08, 2011BioSpace - Breaking News
Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic CancerMarch 08, 2011Pharma News - PR Newswire
Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteonMarch 08, 2011Biotech News - PR Newswire
Biovest is Awarded Orphan Drug Status for its Personalized Cancer Vaccine for the Treatment of Mantle Cell Lymphoma in European UnionMarch 07, 2011Pharma News - Business Wire
Talecris Biotherapeutics Receives EU Orphan Drug Designation for Plasmin (Human) as a Treatment for Acute Peripheral Arterial OcclusionMarch 03, 2011Clinical Trials - PR Newswire
Celsion Corporation Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer March 02, 2011BioSpace - Featured Stories
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver CancerMarch 02, 2011Marketwire - Pharma and Biotech
Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive DisordersMarch 02, 2011Pharma News - PR Newswire
Pervasis Therapeutics Receives Orphan Drug Designation in Europe for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis March 01, 2011BioSpace - Breaking News
FDAAdvisoryCommittee.com to Webcast Discussions on Drug Development for Orphan and Rare DiseasesMarch 01, 2011Marketwire - Pharma and Biotech
Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing HemodialysisMarch 01, 2011Pharma News - PR Newswire
Russian anticancer medicine granted orphan drug status in USFebruary 28, 2011Pharmaceutical - Moreover
Orphan Europe Selects Accredo Health Group to Distribute Carbaglu(R)February 28, 2011Marketwire - Pharma and Biotech
MEDUNIK CANADA: A TEAM STRONGLY COMMITTED TO BRINGING NOVEL ORPHAN DRUGS TO CANADIANS WITH RARE DISEASESFebruary 28, 2011Biotech News - PR Newswire
Ohman axes rating on Swedish Orphan Biovitrum to "neutral"February 25, 2011Pharmaceutical - Moreover
Ohman cuts Swedish Orphan Biovitrum to "neutral"February 25, 2011Pharmaceutical - Moreover
PHARMSYNTHEZ GRANTED ORPHAN DRUG DESIGNATION FOR VIREXXA IN THE USFebruary 25, 2011Pharma News - PharmiWeb
iBio Announces Acquisition of Fabry Disease Orphan Drug Designation and Development ProgramFebruary 23, 2011Biotech News - Business Wire
Swedish Orphan Biovitrum Full Year Report 2010February 23, 2011Marketwire - Pharma and Biotech
Fate Therapeutics Announces Emerging Data From Proof-of-Concept FT1050 Clinical Trial and Receives Orphan Drug DesignationFebruary 21, 2011Clinical Trials - PR Newswire
miRagen Therapeutics Receives Orphan Drug Designation for MGN-4893 for the Treatment of Polycythemia VeraFebruary 17, 2011FDA News - Business Wire
Cerus Corporation's INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP) February 16, 2011BioSpace - Breaking News
Cerus' INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP)February 16, 2011FDA News - Business Wire
BrainStorm Cell Therapeutics Inc. Receives FDA Orphan Drug Designation for NurOwn(TM) in the Treatment of Amyotrophic Lateral Sclerosis February 14, 2011BioSpace - Breaking News
BrainStorm&rsquo;s NurOwn Gets Orphan StatusFebruary 14, 2011Contract Pharma
BrainStorm Receives FDA Orphan Drug Designation for NurOwn™ in the Treatment of Amyotrophic Lateral SclerosisFebruary 14, 2011FDA News - Business Wire
FDA Gives NeuralStem Inc.'s Experimental ALS Treatment Orphan Status February 10, 2011BioSpace - Breaking News
FDA Gives Neuralstem's Experimental ALS Treatment Orphan StatusFebruary 09, 2011Health News - Fox Business
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALSFebruary 09, 2011Pharma News - PR Newswire
FDA Grants Orphan Drug Designation to Bayer HealthCare AG's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors February 04, 2011BioSpace - Breaking News
Bayer's regorafenib gets orphan drug designationFebruary 04, 2011FierceBiotech
FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal TumorsFebruary 04, 2011Pharma News - PR Newswire
Orphan Drug Designation WorkshopFebruary 03, 2011Biotechnology - Moreover
Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan DrugsFebruary 03, 2011Pharma News - PR Newswire
FDA Awards EGEN, Inc. Orphan - Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer February 02, 2011BioSpace - Breaking News
FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian CancerFebruary 02, 2011Clinical Trials - PR Newswire
Regulatory Roundup: FDA Holds Workshop on Orphan DrugsFebruary 02, 2011Biotechnology - Moreover
NPS soars on positive Ph3 data for orphan SBS drugJanuary 31, 2011FierceBiotech
KGI to Celebrate Rare Disease Day With Orphan Drug WorkshopJanuary 31, 2011Medical Pharma - PR Newswire
RRD partners with NIH for orphan drug developmentJanuary 28, 2011Pharmaceutical - Moreover
Fourth FDA Orphan Drug Designation Workshop Scheduled for Feb. 28 - March 1, 2011January 27, 2011Pharma News - PR Newswire
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)January 27, 2011Marketwire - Pharma and Biotech
Alnylam Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation from European Medicines Evaluation Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis January 25, 2011BioSpace - Breaking News
BioSante Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine January 25, 2011BioSpace - Breaking News
BioSante Pharma receives orphan drug statusJanuary 25, 2011Health News - CNBC
Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated AmyloidosisJanuary 25, 2011Pharma News - Business Wire
BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer VaccineJanuary 25, 2011FDA News - Business Wire
Mobius Theraputics??? Granted Orphan Drug Designation for Cornea Indication January 21, 2011BioSpace - Breaking News
Mobius Therapeutics(TM) Granted Orphan Drug Designation for Cornea IndicationJanuary 21, 2011Marketwire - Pharma and Biotech
ZIOPHARM, Inc. Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency January 20, 2011BioSpace - Breaking News
Soligenix Receives FDA Orphan Drug Designation for RiVax(TM) for the Prevention of Ricin Intoxication January 20, 2011BioSpace - Breaking News
Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin IntoxicationJanuary 20, 2011Biotech News - PR Newswire
ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines AgencyJanuary 20, 2011FDA News - Business Wire
<b>CureFAKtor Pharmaceuticals</b> Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer January 18, 2011BioSpace - Breaking News
CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic CancerJanuary 18, 2011Biotech News - PR Newswire
Swedish Orphan Biovitrum and BL&H Co., Ltd sign distribution agreement for South KoreaJanuary 11, 2011Marketwire - Pharma and Biotech
Exelixis, Inc.'s XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib January 10, 2011BioSpace - Breaking News
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name CabozantinibJanuary 10, 2011FDA News - Business Wire
Optimer Pharmaceuticals, Inc. Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection January 04, 2011BioSpace - Breaking News
Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile InfectionJanuary 04, 2011Biotech News - PR Newswire
Senesco Technologies, Inc. Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status from FDA for Treatment of Multiple Myeloma January 03, 2011BioSpace - Breaking News
Senesco Technologies’ Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status from FDA for Treatment of Multiple MyelomaJanuary 03, 2011Pharma News - Business Wire
Swedish Orphan Biovitrum Drops Joint Project with Symphogen A/S December 30, 2010BioSpace
Swedish Orphan Biovitrum Returns Development Rights to Sym001 to SymphogenDecember 30, 2010Marketwire - Pharma and Biotech
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Receives Orphan Drug Status Designation for CEQ508 for the Treatment of Familial Adenomatous Polyposis December 29, 2010BioSpace - Breaking News
Marina Biotech Receives Orphan Drug Status Designation for CEQ508 for the Treatment of Familial Adenomatous PolyposisDecember 29, 2010Marketwire - Pharma and Biotech
Pharming and Swedish Orphan Biovitrum announce first sales of Ruconest in EuropeDecember 28, 2010Marketwire - Pharma and Biotech
FORMER HIV drug developer Avexa is keeping mum about whether it has applied for orphan drug designation for apricitabine (ATC) in the US, but has revealed it has spoken to a handful of large pharmaceutical companies about the asset since July.December 24, 2010Pharmaceutical - Moreover
Advanced Cell Technology Files in Europe for Orphan Drug Designation For Its RPE Cells for Treatment of Stargardt’s DiseaseDecember 23, 2010Pharma News - Business Wire
Swedish Orphan Biovitrum's Long-Lasting Hemophilia A Therapy Receives Orphan Drug Designation in the USDecember 23, 2010Marketwire - Pharma and Biotech
Iran Produces Nanosensor for Measuring Dextromethorphan in Cough DrugsDecember 21, 2010Pharmaceutical - Moreover
Swedish Orphan Biovitrum to increase the availability of Willfact(R) to von Willebrand patients as LFB BIOMEDICAMENTS has received additional European regulatory approvalsDecember 20, 2010Marketwire - Pharma and Biotech
Children's Hospitals and Clinics of Minnesota Applauds Fix on 'Orphan Drug' CoverageDecember 16, 2010Medical Pharma - PR Newswire
Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid LeukaemiaDecember 14, 2010Pharmaceutical - Moreover
Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian primera administración a paciente de su proteína de fusión Factor VIII Fc recombinante de acción duradera en ensayo de homologación mundialDecember 13, 2010Pharma News - Business Wire
QLT Ophthalmics, Inc. (QOI) Receives Orphan Drug Designation for QLT091001 to Treat Retinitis Pigmentosa December 08, 2010BioSpace - Breaking News
Orphan Drug Discounts Ended for Children’s HospitalsDecember 07, 2010New York Times- Pharmaceuticals
NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury (MRW)December 06, 2010Pharmaceutical - Moreover
Samenvatting: Biogen Idec en Swedish Orphan Biovitrum maken behandeling van eerste patiënt bekend in mondiaal registratief onderzoek naar langdurig recombinant factor VIII Fc fusie-eiwitDecember 06, 2010Pharma News - Business Wire
FDA grants orphan drug status to NeuroVive Pharma NeuroSTATDecember 06, 2010Pharmaceutical - Moreover
Biogen Idec et Swedish Orphan Biovitrum annoncent le dosage réussi du premier patient dans le cadre d’un essai mondial d’homologation de la protéine de fusion Fc-facteur VIII recombinante à action prolongéeDecember 06, 2010Pharma News - Business Wire
Biogen Idec und Swedish Orphan Biovitrum melden erstmalige Gabe ihres langwirkenden rekombinanten Faktor-VIII-Fc-Fusionsproteins an Patienten in globaler ZulassungsstudieDecember 06, 2010Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano la prima somministrazione della proteina di fusione ricombinante a lungo termine costituita dal fattore VIII...December 06, 2010Pharma News - Business Wire
NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain InjuryDecember 06, 2010Marketwire - Pharma and Biotech
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion ProteinDecember 06, 2010Pharma News - Business Wire
Cleveland BioLabs' CBLB502 Granted Orphan Drug Status From FDA for Prevention of Death Following a Potentially Lethal Dose of Total Body Irradiation During or After a Radiation DisasterNovember 30, 2010Marketwire - Pharma and Biotech
Elorac, Inc. Announces Orphan Drug Designation for Novel Topical Treatment for Pruritus in Cutaneous T-cell Lymphoma (CTCL)November 30, 2010Pharma News - Business Wire
EBE and EuropaBio hail EU Orphan Medicinal Products Regulation a successNovember 29, 2010Biotechnology - Moreover
CEO Leaves Swedish Orphan Biovitrum November 29, 2010BioSpace - Breaking News
CEO Martin Nicklasson Leaves Swedish Orphan BiovitrumNovember 25, 2010Marketwire - Pharma and Biotech
Almac Adds Late Stage Customisation Suite to Assist Orphan Drug / Niche Product Launches Into EuropeNovember 25, 2010Biotech News - PR Newswire
INTERVIEW: Shire CEO Says Orphan Drugs Focus Good Pharma ModelNovember 22, 2010Health News - Fox Business
Close legal loophole allowing highcost orphan drugs doctors sayNovember 19, 2010Pharmaceutical - Moreover
Advanced Life Sciences Holdings, Inc. Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury November 18, 2010BioSpace - Breaking News
Advanced Life Sciences Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung InjuryNovember 18, 2010Biotech News - PR Newswire
Orphan Medicinal Product Status to Active Biotech's 57-57 project recommendedNovember 18, 2010Marketwire - Pharma and Biotech
Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell DiseaseNovember 15, 2010Biotech News - PR Newswire
Celsion Corporation Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox(R) to Treat Primary Liver Cancer November 11, 2010BioSpace - Breaking News
Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver CancerNovember 11, 2010Clinical Trials - PR Newswire
German Pharmaceutical Law Removes Incentives For Orphan Drug RNovember 11, 2010Biotechnology - Moreover
German Pharmaceutical Law Removes Incentives For Orphan Drug R&DNovember 11, 2010Pharmaceutical - Moreover
Semafore Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic Leukemia November 09, 2010BioSpace - Breaking News
Synageva BioPharma Receives European Orphan Medicinal Product Designation for SBC-102 for Lysosomal Acid Lipase DeficiencyNovember 09, 2010Pharma News - Business Wire
Semafore Pharmaceuticals Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic LeukemiaNovember 09, 2010FDA News - Business Wire
Omeros Identifies Orphan GPCR-Targeting Compound Potentiating Chemotherapeutic ActivityNovember 09, 2010Biotech News - PR Newswire
Swedish Orphan Biovitrum's co-promotion rights for Mimpara® sold back to AmgenNovember 05, 2010Pharma News - PharmiWeb
Swedish Orphan Biovitrum's Co-Promotion Rights for Mimpara(R) Sold Back to AmgenNovember 05, 2010Marketwire - Pharma and Biotech
Emergent BioSolutions Receives Orphan Drug Designation for Its Investigational Monoclonal Antibody for the Treatment of Inhalation AnthraxNovember 04, 2010FDA News - Business Wire
Swedish Orphan Biovitrum And Announce A Distribution Agreement For Iron Sucrose Rechon In Europe November 03, 2010BioSpace - Breaking News
Swedish Orphan Biovitrum AB (publ): Swedish Orphan Biovitrum and Dongbao Group announce a distribution agreement for Iron Sucrose Rechon in EuropeNovember 03, 2010Pharmaceutical - Moreover
Swedish Orphan Biovitrum and Dongbao Group announce a distribution agreement for Iron Sucrose Rechon in EuropeNovember 03, 2010Marketwire - Pharma and Biotech
Neogenix Oncology® Receives FDA Orphan Drug Status for Ensituximab (NPC-1C) for Treatment of Pancreatic CancerNovember 01, 2010FDA News - Business Wire
AOP Orphan Gives €1.25M Up Front in Deal for Shield’s Phase III-Stage Iron Therapy ProductNovember 01, 2010Inside Industry - Gen
Clinical Data, Inc. Granted Orphan Drug Designation for PRX-8066 for Pulmonary Arterial HypertensionNovember 01, 2010Pharma News - Business Wire
Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021November 01, 2010Pharma News - PR Newswire
Strativa Pharma enters amended agreement with Swedish Orphan Biovitrum for NascobalOctober 29, 2010Pharmaceutical - Moreover
Strativa Pharmaceuticals signs agreement with Swedish Orphan Biovitrum for NascobalOctober 27, 2010Pharmaceutical - Moreover
Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum ...October 26, 2010Pharmaceutical - Moreover
Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal®October 26, 2010Pharma News - PR Newswire
Europäische Arzneimittelbehörde beurteilt Antrag der Cytonet GmbH & Co. KG auf Orphan Drug-Status für Leberzelltherapie positivOctober 26, 2010Pharma News - Business Wire
Inspiration Biopharmaceuticals' OBI-1 Receives Orphan Drug Designation in EuropeOctober 19, 2010Medical Pharma - PR Newswire
Ipsen: OBI-1 Receives Orphan Drug Designation in EuropeOctober 19, 2010FDA News - Business Wire
S*BIO's JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission (EC) for the Treatment of Myelofibrosis (MF)October 18, 2010Biotech News - PR Newswire
Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Hodgkin Lymphoma by the European CommissionOctober 15, 2010Pharma News - Business Wire
FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010October 13, 2010Pharma News - PR Newswire
Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56)October 13, 2010Pharma News - PR Newswire
NeuroVive Pharma NeuroSTAT gets orphan drug statusOctober 12, 2010Pharmaceutical - Moreover
Genta Incorporated Tesetaxel Granted Orphan Drug Designation for Gastric Cancer by European Medicines Evaluation Agency October 11, 2010BioSpace - Featured Stories
Tesetaxel Granted Orphan Drug Designation for Gastric Cancer by European Medicines AgencyOctober 11, 2010Pharma News - Business Wire
NeuroVive receives Orphan Drug Designation in Europe for moderate and severe traumatic brain injuryOctober 11, 2010Marketwire - Pharma and Biotech
Symphogen and Swedish Orphan Biovitrum receive U.S. orphan drug designation for Rozrolimupab in ITPOctober 06, 2010Marketwire - Pharma and Biotech
AEterna Zentaris Announces Orphan Drug AEZS-130 (Macimorelin, SolorelTM) Interim Phase 3 Data Analysis Shows Potential for 2011 Filing as Oral Diagnostic Test for Adult Growth Hormone Deficiency (AGHD) October 05, 2010BioSpace - Breaking News
Prolor Biotech Gets Orphan Drug Designation for Growth Hormone Deficiency TreatmentOctober 05, 2010Health News - Fox Business
Aeterna Zentaris Announces Orphan Drug AEZS-130 (Macimorelin, Solorel(TM)) Interim Phase 3 Data Analysis Shows Potential for 2011 Filing as Oral Diagnostic Test for Adult Growth Hormone Deficiency (AGHD)October 05, 2010Biotech News - PR Newswire
PROLOR Biotech Rallies on Orphan Status for Growth Therapy October 05, 2010BioSpace - Breaking News
Prolor growth hormone gets 'orphan drug' statusOctober 05, 2010Health News - CNBC
Orphan Drug Report 2010October 05, 2010Pharmaceutical - Moreover
PROLOR Biotech's Longer-Acting Human Growth Hormone Receives Orphan Drug Designation in the U.S.October 05, 2010Biotech News - PR Newswire
iCo Therapeutics Inc. Oral Amphotericin Program Receives FDA Orphan Drug Status September 29, 2010BioSpace - Breaking News
iCo Therapeutics Oral Amphotericin Program Receives FDA Orphan Drug StatusSeptember 29, 2010Marketwire - Pharma and Biotech
AMT gene therapy receives orphan drug status in USASeptember 24, 2010Biotechnology - Moreover
AMT Receives Orphan Drug Designation From the U.S. Food and Drug Administration Duchenne Muscular Dystrophy Gene TherapySeptember 24, 2010Biotech News - PR Newswire
Ziopharm Oncology Treatment for T-cell Lymphoma Receives Orphan Drug DesignationSeptember 23, 2010Health News - Fox Business
ZIOPHARM Oncology, Inc.'s Lymphoma Drug Darinaparsin Gets FDA Orphan Status September 23, 2010BioSpace - Breaking News
Ziopharm drug candidate awarded orphan drug statusSeptember 23, 2010Health News - CNBC
ZIOPHARM Receives FDA Orphan Drug Designation for Darinaparsin in the Treatment of Peripheral T-cell LymphomaSeptember 23, 2010FDA News - Business Wire
Swedish Orphan Biovitrum's Hemophilia A Therapy Receives European Commission Orphan Drug DesignationSeptember 23, 2010Marketwire - Pharma and Biotech
UPDATE 1-Catalyst's infantile spasm drug gets FDA orphan statusSeptember 21, 2010Pharmaceutical - Moreover
PTC Therapeutics Receives $1.6M from FDA Orphan Drug GrantSeptember 21, 2010Inside Industry - Gen
PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant to Support an Ongoing Phase 3 Study in Cystic FibrosisSeptember 21, 2010Biotech News - PR Newswire
Shire joins orphan disease rush with $500 million Acceleron dealSeptember 09, 2010Pharmaceutical - Moreover
Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases in Deal Worth up to $498 Million September 09, 2010BioSpace
Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire plc on Novel Muscle Therapeutics for Orphan Diseases; to Make Upfront Payment of $45 Million with Potential for Additional $288 Million September 09, 2010BioSpace
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron PharmaSeptember 09, 2010Biotech News - PR Newswire
Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan DiseasesSeptember 09, 2010Pharma News - Business Wire
Issues Surrounding Orphan Disease and Orphan Drug Policies in EuropeSeptember 08, 2010Pharmaceutical - Moreover
Research and Markets: Orphan Drug Report 2010 Profiles More than 80 Drugs Out TodaySeptember 06, 2010Pharma News - Business Wire
Pompe drug wins orphan statusSeptember 01, 2010Pharmaceutical - Moreover
Pfizer Makes Another Move into Orphan Drug Development with Purchase of FoldRxSeptember 01, 2010Inside Industry - Gen
Stromedix drug candidate gets orphan designationAugust 31, 2010Biotechnology - Moreover
Stromedix, Inc. Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary Fibrosis August 31, 2010BioSpace - Breaking News
New number of shares and votes in Swedish Orphan Biovitrum AB (publ)August 31, 2010Marketwire - Pharma and Biotech
Stromedix Receives FDA Orphan Drug Designation for STX-100 for the Treatment of Idiopathic Pulmonary FibrosisAugust 31, 2010FDA News - Business Wire
BioMarin Pharmaceutical Inc. (BMRN) Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe DiseaseAugust 30, 2010Pharmaceutical - Moreover
BioMarin's Pompe disease drug gets orphan statusAugust 30, 2010Health News - CNBC
BioMarin Pharmaceutical Inc. Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease August 30, 2010BioSpace - Breaking News
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe DiseaseAugust 30, 2010Biotech News - PR Newswire
Swedish Orphan Biovitrum AB's Kineret(R) has Received Orphan Drug Designation in the USA August 26, 2010BioSpace - Breaking News
LFB S.A.'s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic Leukemia August 26, 2010BioSpace - Breaking News
LFB's Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic LeukemiaAugust 26, 2010FDA News - Business Wire
Swedish Orphan Biovitrum's Kineret(R) has Received Orphan Drug Designation in the USAAugust 26, 2010Marketwire - Pharma and Biotech
FDA Grants Orphan Drug Status for to-BBB's Lead Product August 23, 2010BioSpace - Breaking News
Soligenix Announces Award of $1.2 Million FDA Orphan Products Development GrantAugust 23, 2010Biotech News - PR Newswire
Acceleron Pharma Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy August 19, 2010BioSpace - Breaking News
Acceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular DystrophyAugust 19, 2010FDA News - Business Wire
BioMarin snares orphan disease upstart in $115M buyoutAugust 19, 2010Pharmaceutical - Moreover
ImmunoGen's Small-Cell Lung Cancer Treatment Receives Orphan Drug DesignationAugust 18, 2010Health News - Fox Business
UPDATE 1-ImmunoGen lung cancer drug gets FDA orphan statusAugust 18, 2010Biotechnology - Moreover
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung CancerAugust 18, 2010Pharma News - Business Wire
NephRx Corporation Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function August 18, 2010BioSpace - Breaking News
BioMarin snares orphan drug upstart in $115M buyoutAugust 18, 2010FierceBiotech
NephRx Corp. Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft FunctionAugust 18, 2010Biotech News - PR Newswire
BioMimetic Therapeutics drug gets orphan statusAugust 12, 2010Health News - CNBC
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteochondritis DissecansAugust 12, 2010FDA News - Business Wire
Centric Health Resources Presents Third Annual Ultra Orphan Conference 2010, Emerging Commercialization Strategies for Addressing the Needs of Ultra-August 11, 2010Pharmaceutical - Moreover
Centric Health Resources Presents Third Annual Ultra Orphan Conference 2010, “Emerging Commercialization Strategies for Addressing the Needs of Ultra- Orphan Patients”August 11, 2010Pharma News - Business Wire
Reportlinker Adds Global Markets for Orphan DrugsAugust 10, 2010Pharma News - PR Newswire
YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation August 10, 2010Contract Pharma
YM BioSciences granted Orphan Drug Designation for CYT387August 10, 2010Biotech News - PR Newswire
DUSA Pharmaceuticals to Stop Levulan Photodynamic Cancer Trial as FDA Denies Orphan Status August 09, 2010BioSpace - Breaking News
DUSA Pharmaceuticals Receives Response From FDA on Orphan Drug Designation StatusAugust 06, 2010Pharma News - PR Newswire
Orphan Drug Industry in the Development of the Biotechnology IndustryAugust 06, 2010Biotechnology - Moreover
XOMA (US) LLC Release: XOMA 052 Designated Orphan Drug by FDA for Treatment of Behcet's Disease August 04, 2010BioSpace - Breaking News
FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding DisorderAugust 02, 2010Pharma News - PR Newswire
Biovest wins orphan drug status for cancer vaxJuly 29, 2010FierceVaccines
Biovest International product gets orphan drug status from FDAJuly 26, 2010Health News - BizJournals.com
FDA Grants Biovest International, Inc. Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID(R), Targeting Mantle Cell Lymphoma July 26, 2010BioSpace
FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID®, Targeting Mantle Cell LymphomaJuly 26, 2010FDA News - Business Wire
Centric Health Resources Identifies Emerging Channels to Reach Patients in Specialty and Orphan Markets at Bio/Pharmaceutical and Medical Device ForumJuly 26, 2010Pharmaceutical - Moreover
Global Markets for Orphan DrugsJuly 19, 2010Biotechnology - Moreover
Keryx's shares rally on new orphan drug title for perifosineJuly 15, 2010FierceBiotech
Keryx's perifosine gets second orphan drug statusJuly 15, 2010Health News - CNBC
Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX-0401 (Perifosine) for the Treatment of NeuroblastomaJuly 14, 2010Pharma News - PR Newswire
Resumen: Biogen Idec y Swedish Orphan Biovitrum presentan datos sobre terapia de larga duración para la hemofilia B en el Congreso de la Federación Mundial de la HemofiliaJuly 13, 2010Pharma News - Business Wire
Biogen Idec und Swedish Orphan Biovitrum präsentieren auf dem Kongress der World Federation of Hemophilia Daten zu lang wirkender Hämophilie-B-TherapieJuly 12, 2010Pharma News - Business Wire
Biogen Idec et Swedish Orphan Biovitrum présentent les résultats du traitement de l'hémophilie B à action prolongée lors du congrès de la Fédération mondiale de l'hémophilieJuly 12, 2010Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum presentano i dati sulla terapia per l'emofilia B a lungo termine al congresso della Federazione mondiale per l'emofiliaJuly 12, 2010Pharma News - Business Wire
Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the Congress July 12, 2010BioSpace - Breaking News
Samenvatting: Biogen Idec en Swedish Orphan Biovitrum presenteren gegevens over langdurige behandeling hemofilie B tijdens World Federation of Hemophilia CongressJuly 12, 2010Biotech News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia CongressJuly 12, 2010Pharma News - Business Wire
Biogen Idec und Orphan Biovitrum aus Schweden beschließen Weiterentwicklung von langwirkendem Hämophilie-A-Medikament in einer ZulassungsstudieJuly 12, 2010Pharma News - Business Wire
Biogen Idec et Swedish Orphan Biovitrum annoncent leur décision de soumettre leur traitement de l’hémophilie A à action prolongée à un essai d’homologationJuly 09, 2010Pharma News - Business Wire
Biogen Idec, Inc. (North Carolina) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial July 09, 2010BioSpace - Breaking News
Biogen, Inc. and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial July 09, 2010BioSpace - Breaking News
Samenvatting: Biogen Idec en Swedish Orphan Biovitrum melden promotie van langdurige hemofilie A-therapie tot een registrationeel onderzoekJuly 09, 2010Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano decisione di far avanzare terapia per emofilia A a lungo termine a sperimentazione registrativaJuly 09, 2010Pharma News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational TrialJuly 09, 2010Marketwire - Pharma and Biotech
Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian decisión de avanzar la terapia de larga duración para la hemofilia A en ensayo clínico de registroJuly 09, 2010Biotech News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational TrialJuly 09, 2010Pharma News - Business Wire
Synageva BioPharma Receives Orphan Drug Designation for SBC-102 for Lysosomal Acid Lipase DeficiencyJuly 07, 2010FDA News - Business Wire
Swedish Orphan Biovitrum AB (publ) (SE) - Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European marketsJuly 06, 2010Pharmaceutical - Moreover
Angeion Corporation Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 July 06, 2010BioSpace - Breaking News
Angion Biomedica Corp. Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 July 06, 2010BioSpace
Angion Biomedica Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3July 06, 2010FDA News - Business Wire
Swedish Orphan Biovitrum AB (publ): Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European marketsJuly 06, 2010Pharmaceutical - Moreover
Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European marketsJuly 06, 2010Marketwire - Pharma and Biotech
NORD Calls for Statement of Policy on Orphan Drug DevelopmentJune 29, 2010Pharma News - PR Newswire
Omeros Successfully Unlocks Orphan GPCRsJune 29, 2010Biotech News - PR Newswire
Tarix Pharmaceuticals' TXA127 Receives FDA Orphan Drug Designation for Stem Cell EngraftmentJune 28, 2010Pharma News - PR Newswire
Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of AcromegalyJune 28, 2010Biotech News - PR Newswire
AVEO Gets Orphan Designation From EU RegulatorsJune 24, 2010Biotechnology - Moreover
Avraham Pharmaceuticals Ltd. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency June 24, 2010BioSpace - Breaking News
t2cure GmbH???s Cellular Therapeutic Receives Orphan Drug Designation from FDA, European Medicines Evaluation Agency Recommendation for Buerger???s Disease June 24, 2010BioSpace
Aveo cancer drug gets orphan status in EuropeJune 24, 2010Health News - CNBC
AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Evaluation Agency June 24, 2010BioSpace - Breaking News
t2cure's Cellular Therapeutic Receives Orphan Drug Designation from FDA, EMA Recommendation for Buerger's DiseaseJune 24, 2010Biotech News - PR Newswire
AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines AgencyJune 24, 2010Pharma News - Business Wire
Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitusJune 22, 2010Biotech News - PR Newswire
Allos Therapeutics, Inc.' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European Commission June 17, 2010BioSpace - Breaking News
OBI-1 Developed by Ipsen and Inspiration Biopharmaceuticals Has Obtained a Positive Opinion for the Orphan Drug Status in Europe June 17, 2010BioSpace - Breaking News
Raptor Wins EU Orphan Status for Kidney Disease DrugJune 17, 2010Pharmaceutical - Moreover
Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European CommissionJune 17, 2010Pharma News - Business Wire
OBI-1 Developed by Ipsen and Inspiration Has Obtained a Positive Opinion for the Orphan Drug Status in EuropeJune 17, 2010Pharma News - Business Wire
Raptor’s DR Cysteamine Gets Orphan Designation From EMAJune 16, 2010Pharmaceutical - Moreover
Raptor Pharmaceutical Inc.'s DR Cysteamine Receives Orphan Medicinal Product Designation From the European Medicines Evaluation Agency June 15, 2010BioSpace - Breaking News
UK grants Quark orphan drug statusJune 15, 2010Health News - BizJournals.com
Quark Granted European Orphan Drug Status for QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant PatientsJune 15, 2010Pharma News - PR Newswire
ImmunoCellular Therapeutics, Ltd Granted Orphan Drug Status for ICT-107 June 11, 2010BioSpace - Breaking News
ImmunoCellular Therapeutics Granted Orphan Drug Status for ICT-107June 11, 2010FDA News - Business Wire
FDA gives orphan status to BioSante leukemia drugJune 07, 2010Health News - CNBC
BioSante Announces FDA Orphan Drug Designation for GVAX Chronic Myeloid Leukemia Cancer VaccineJune 07, 2010FDA News - Business Wire
ACT Biotech Receives Orphan Drug Designation for Telatinib, an Orally Available and Highly Selective Kinase Inhibitor, in Gastric CancerJune 02, 2010FDA News - Business Wire
Trappsol(R) Cyclo(TM) Awarded Orphan Drug StatusJune 01, 2010Marketwire - Pharma and Biotech
Repligen drug gets FDA orphan drug statusMay 24, 2010Health News - CNBC
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's AtaxiaMay 24, 2010Biotech News - PR Newswire
Allos Therapeutics, Inc.'s Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer May 18, 2010BioSpace
Allos Therapeutics’ Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder CancerMay 18, 2010FDA News - Business Wire
AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the of the May 17, 2010BioSpace
NeoPharm Drug Gets Orphan Designation May 17, 2010Contract Pharma
Orphan drug status for Aeterna's cancer treatmentMay 17, 2010Health News - CNBC
NeoPharm Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary FibrosisMay 17, 2010FDA News - Business Wire
Aeterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines AgencyMay 17, 2010Medical Pharma - PR Newswire
Swedish Orphan Biovitrum and Biomodels to develop assay for mucositis risk in cancer treatmentMay 11, 2010Marketwire - Pharma and Biotech
Aeterna Zentaris Cancer Drug Gets Orphan Drug Designation May 07, 2010Contract Pharma
US FDA seeks input on orphan product regulationMay 06, 2010Pharmaceutical - Moreover
Swedish Orphan Biovitrum presents first positive Kiobrina(R) clinical phase II dataMay 06, 2010Marketwire - Pharma and Biotech
Osiris Therapeutics Receives FDA Orphan Drug Designation for Stem Cell Treatment for Type 1 DiabetesMay 04, 2010FDA News - Business Wire
Synageva BioPharma Files for Orphan Drug Designation for SBC-102, Being Developed to Be the First Enzyme Replacement Therapy to Treat Lysosomal Acid Lipase Deficiency – a Progressive, Often Fatal DiseaseMay 04, 2010FDA News - Business Wire
Valeant to buy orphan drug developer Aton for $318mnMay 04, 2010Pharmaceutical - Moreover
Valeant to buy orphan drug developer Aton for $318MMay 03, 2010FierceBiotech
ImmunoCellular Files Orphan Drug Application for ICT-107May 03, 2010Pharma News - Business Wire
Swedish Orphan Biovitrum AB Has Decided To Move Kiobrina(R) Into Phase III Development April 21, 2010BioSpace - Breaking News
Swedish Orphan Biovitrum has decided to move Kiobrina(R) into phase III developmentApril 21, 2010Marketwire - Pharma and Biotech
CytRx’s Bafetinib Receives Positive Opinion from the Committee for Orphan Medicinal Products in the European Union for Treatment of CMLApril 20, 2010Pharma News - Business Wire
Swedish Orphan Nabs 10-Year Distribution Rights to Pharming’s HAE Therapy in EuropeApril 15, 2010GEN News Highlights
Swedish Orphan Biovitrum and Pharming sign Rhucin(R) distribution agreementApril 15, 2010Marketwire - Pharma and Biotech
Orphan Drugs To Plug Pipeline GapsApril 14, 2010Pharmaceutical - Moreover
Orphan Drugs to Create Paradigm Shift in the Pharmaceutical IndustryApril 08, 2010Pharmaceutical - Moreover
Swedish Orphan Biovitrum launches Willfact(R) under its distribution agreement with LFB BIOMEDICAMENTSApril 08, 2010Marketwire - Pharma and Biotech
Biovitrum (SE) - Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology LimitedApril 07, 2010Biotechnology - Moreover
Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology LimitedApril 06, 2010Biotechnology - Moreover
Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Ph...April 06, 2010Pharmaceutical - Moreover
Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry!April 06, 2010Biotech News - PR Newswire
Swedish Orphan Biovitrum extends Cyanokit(R) cooperation with Merck SeronoApril 01, 2010Marketwire - Pharma and Biotech
Orphan Drug Market Catches Pharma's EyeMarch 27, 2010Pharmaceutical - Moreover
Diamyd Medical AB Granted Orphan Drug Designation in the US March 23, 2010BioSpace - Breaking News
Diamyd Granted Orphan Drug Designation in the USMarch 23, 2010FDA News - Business Wire
Diamyd Medical: Diamyd granted Orphan Drug Designation in the USMarch 23, 2010Pharma News - Business Wire
BioSante Pharmaceuticals, Inc. Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug Designation March 23, 2010BioSpace - Breaking News
BioSante Announces Additional Positive Leukemia Vaccine Results and Second FDA Orphan Drug DesignationMarch 23, 2010FDA News - Business Wire
Swedish Orphan Biovitrum updates European Kepivance(R) labelMarch 23, 2010Marketwire - Pharma and Biotech
Carbaglu (carglumic acid"Orphan Pharmaceutical Company) approved for treating condition that causes elevated ammonia levelsMarch 19, 2010Pharmaceutical - Moreover
Allon Receives European Orphan Drug Status for DavunetideMarch 17, 2010Marketwire - Pharma and Biotech
BioSante cancer vaccine gets 'orphan drug' statusMarch 15, 2010Health News - CNBC
BioSante Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine March 15, 2010BioSpace - Breaking News
BioSante Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer VaccineMarch 15, 2010FDA News - Business Wire
Swedish Orphan Biovitrum has agreed to an additional Kineret(R) drug campaign with AmgenMarch 12, 2010Marketwire - Pharma and Biotech
Gehrig's disease drug from Cytokinetics wins orphan statusMarch 11, 2010Health News - BizJournals.com
Bayer&rsquo;s Cipro CF Drug Gets Orphan Designation March 11, 2010Contract Pharma
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic FibrosisMarch 11, 2010Pharma News - PR Newswire
FDA Grants Orphan Status to Cytokinetics Treatment for Lou Gehrig’s DiseaseMarch 10, 2010Biotechnology - Moreover
Cytokinetics, Inc. Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis March 10, 2010BioSpace - Breaking News
Cytokinetics gets orphan drug status for ALS drugMarch 10, 2010FierceBiotech
FDA grants Cytokinetics treatment orphan statusMarch 10, 2010Health News - CNBC
Cytokinetics, Inc.'s Lou Gehrig's Drug Gets Orphan Status March 10, 2010BioSpace
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary FibrosisMarch 10, 2010FDA News - Business Wire
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral SclerosisMarch 10, 2010Marketwire - Pharma and Biotech
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU March 09, 2010BioSpace - Breaking News
FDA Grants Orphan Drug Designation To ImmunoGen IMGN901 CompoundMarch 09, 2010Biotechnology - Moreover
ImmunoGen cancer drug gets 'orphan drug' statusMarch 08, 2010Health News - CNBC
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU COMPMarch 08, 2010FDA News - Business Wire
ImmuneRegen BioSciences, Inc. Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fibrosis March 04, 2010BioSpace - Breaking News
ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary FibrosisMarch 04, 2010Marketwire - Pharma and Biotech
Research and Markets: Opportunities in Orphan Drugs: Strategies for Developing Maximum Returns from Niche IndicationsMarch 04, 2010Pharma News - Business Wire
Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt???s Macular Dystrophy March 02, 2010BioSpace - Breaking News
Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt’s Macular DystrophyMarch 02, 2010FDA News - Business Wire
AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the March 01, 2010BioSpace
Ariad cancer treatment gets 'orphan drug' statusMarch 01, 2010Health News - CNBC
Æterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the European Medicines AgencyMarch 01, 2010Biotech News - PR Newswire
ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid LeukemiaMarch 01, 2010Pharma News - Business Wire
International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual ReportFebruary 27, 2010Medical Pharma - PR Newswire
Research and Markets: Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian MarketFebruary 26, 2010Pharma News - Business Wire
Lithera Obtains Orphan Drug Product Designation for LIPO-102February 23, 2010Pharmaceutical - Moreover
New Report Analyzes the Future of Orphan Disease TherapeuticsFebruary 23, 2010Marketwire - Pharma and Biotech
Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement February 18, 2010BioSpace
Reportlinker Adds Opportunities in Orphan Drugs: Strategies for Developing Maximum Returns From Niche IndicationsFebruary 18, 2010Medical Pharma - PR Newswire
Biogen Idec Takes Over Development of Hemophilia Therapies in Deal with Swedish Orphan BiovitrumFebruary 18, 2010GEN News Highlights
Karolinska Development AB: European Medicines Evaluation Agency Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment February 18, 2010BioSpace - Breaking News
Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia TreatmentFebruary 18, 2010Pharma News - PR Newswire
Samenvatting: Biogen Idec en Swedish Orphan Biovitrum werken hun hemofiliesamenwerking bijFebruary 18, 2010Pharma News - Business Wire
Resumen: Biogen Idec y Swedish Orphan Biovitrum modifican acuerdo de alianza en relación con la hemofiliaFebruary 18, 2010Pharma News - Business Wire
Biogen Idec et Swedish Orphan Biovitrum modifient leur accord de partenariat concernant l'hémophilieFebruary 18, 2010Pharma News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership AgreementFebruary 18, 2010Pharma News - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum aggiornano l'accordo di partnership per l'emofiliaFebruary 18, 2010Pharma News - Business Wire
Biogen Idec und Swedish Orphan Biovitrum ändern Partnerschaftsvertrag für HämophilieprojektFebruary 18, 2010Pharma News - Business Wire
Quark drug wins orphan status from FDAFebruary 16, 2010Health News - BizJournals.com
Reportlinker Adds Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian MarketFebruary 16, 2010Pharma News - PR Newswire
EntreMed, Inc. Receives Orphan Drug Designation for ENMD-2076 in Leukemia February 16, 2010BioSpace - Breaking News
EntreMed Receives Orphan Drug Designation for ENMD-2076 in LeukemiaFebruary 16, 2010Pharma News - PR Newswire
Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market AccessFebruary 09, 2010Pharma News - Business Wire
Talecris Drug Gains Orphan Designation February 08, 2010Contract Pharma
Aton Pharma Announces Michael H. Richardson to Head Orphan Drug DivisionFebruary 08, 2010Medical Pharma - PR Newswire
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin DeficiencyFebruary 05, 2010Pharma News - Business Wire
AVI BioPharma, Inc.'s Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy February 05, 2010BioSpace
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular DystrophyFebruary 05, 2010Marketwire - Pharma and Biotech
ERYtech Pharma obtains FDA orphan drug designation for leukemia drugJanuary 28, 2010Biotechnology - Moreover
Erytech leukemia drug Graspa gets orphan statusJanuary 27, 2010Health News - BizJournals.com
EpiCept Receives Orphan Drug Designation for EpiCept™ NP-1 in U.S.January 27, 2010FDA News - Business Wire
Biogen Idec, Orphan Biovitrum partner for hemophilia B drug trialJanuary 26, 2010Biotechnology - Moreover
ERYtech Pharma: FDA Grants Orphan Drug Designation to GRASPA® for Treatment of Acute Lymphoblastic LeukaemiaJanuary 26, 2010Pharma News - Business Wire
Resumen: Biogen Idec y Swedish Orphan Biovitrum anuncian la administración de dosis al primer paciente a través de un ensayo mundial y de registro para el tratamiento de la hemofilia B de acción prolongadaJanuary 25, 2010Pharma News - Business Wire
Samenvatting: Biogen Idec en het Swedish Orphan Biovitrum maken bekend dat de eerste patiënt zijn dosis heeft ontvangen in de hemofilie-B testJanuary 25, 2010Pharma News - Business Wire
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B TherapyJanuary 25, 2010Clinical Trials - Business Wire
Riassunto: Biogen Idec e Swedish Orphan Biovitrum annunciano la somministrazione di dosi al primo paziente nella sperimentazione per la registrazione a livello internazionale della terapia ad azione protratta per l’emofiliaJanuary 25, 2010Clinical Trials - Business Wire
Biogen Idec et Swedish Orphan Biovitrum annoncent le dosage réussi du premier patient dans le cadre d’un essai mondial d’homologation d’une thérapie à action prolongée pour l’hémophilie BJanuary 25, 2010Clinical Trials - Business Wire
Biogen Idec und Swedish Orphan Biovitrum melden die erste Patientenbehandlung mit ihrem langwirkenden Hämophilie-B-Medikament in globaler ZulassungsstudieJanuary 25, 2010Clinical Trials - Business Wire
U.S. Orphan Product Designations More Than Doubled During Last Decade, According to Tufts Center for the Study of Drug DevelopmentJanuary 20, 2010Marketwire - Pharma and Biotech
Octapharma AG Receives Orphan Drug Exclusivity Approval for wilate(R) January 13, 2010BioSpace - Breaking News
Protalix Biotherapeutics's COMP Adopts Positive Opinion for the Orphan Drug Designation for Protalix Biotherapeutics's Taliglucerase Alfa January 13, 2010BioSpace - Breaking News
European Medicines Agency's COMP Adopts Positive Opinion for the Orphan Drug Designation for Protalix's taliglucerase alfaJanuary 13, 2010Clinical Trials - PR Newswire
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand DiseaseJanuary 13, 2010Pharma News - PR Newswire
FDA Grants Orphan Drug Status to Allon Therapeutics, Inc.'s Davunetide for Brain Disease January 12, 2010BioSpace - Breaking News
FDA Grants Orphan Drug Status to Allon's Davunetide for Brain DiseaseJanuary 12, 2010Marketwire - Pharma and Biotech
Clavis Pharma gets orphan drug status, new CEOJanuary 08, 2010FierceBiotech
FDA Grants Orphan Drug Status for Personalized Lymphoma VaccineJanuary 07, 2010FDA News - Business Wire
Research and Markets: The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and ReimbursementJanuary 06, 2010Pharma News - Business Wire
FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010December 23, 2009Pharma News - PR Newswire
European Medicines Evaluation Agency Grants Cell Therapeutics, Inc. Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL) December 21, 2009BioSpace - Breaking News
Cell Therapeutics, Inc. Says Cancer Drug Gets Orphan Status in Europe December 21, 2009BioSpace
European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)December 21, 2009Biotech News - PR Newswire
Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and ReimbursementDecember 15, 2009Biotech News - PR Newswire
Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell DiseaseDecember 09, 2009Biotech News - PR Newswire
BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury TreatmentDecember 08, 2009Clinical Trials - PR Newswire
Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug DesignationFDA News - Business Wire
LFB’s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in Europe for Chronic Lymphocytic LeukemiaClinical Trials - Business Wire



View all the latest news